Are the Covid Unvaxxed Getting Heart Inflation? (Or, Is It Primarily the Vaxxed?) By Brian Simpson
According to the mainstream Covid narrative, such as, F. Flam, “You Thought Covid-19 was Bad: It Gets Worse,” Australian Financial Review, November 5-6, 2022, p. 18, quotes a study from the journal Heart, of 54, 000 British people, which found that those who have had a Covid infection were 2.7 times more likely to develop dangerous blood clotting than those who had not been infected. Yes, but what about those who have been infected, but vaxxed? There is also a recent study about that too, in the Journal of Clinical Medicine. The study deals with the incidence of heart inflammation in 196,992 adults after Covid-19 infection in Israel. It was found that there was not an increased incidence of either pericarditis nor myocarditis in adult patients recovering from Covid-19 infection. Thus, the only remaining reasonable explanation: it must be the vax, although I suppose the elites will plug for climate change.
https://pubmed.ncbi.nlm.nih.gov/35456309/
J Clin Med
. 2022 Apr 15;11(8):2219.
doi: 10.3390/jcm11082219.
The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients-A Large Population-Based Study
Ortal Tuvali 1, Sagi Tshori 2, Estela Derazne 3, Rebecca Regina Hannuna 2, Arnon Afek 3 4, Dan Haberman 1, Gal Sella 1, Jacob George 1
Abstract
Myocarditis and pericarditis are potential post-acute cardiac sequelae of COVID-19 infection, arising from adaptive immune responses. We aimed to study the incidence of post-acute COVID-19 myocarditis and pericarditis. Retrospective cohort study of 196,992 adults after COVID-19 infection in Clalit Health Services members in Israel between March 2020 and January 2021. Inpatient myocarditis and pericarditis diagnoses were retrieved from day 10 after positive PCR. Follow-up was censored on 28 February 2021, with minimum observation of 18 days. The control cohort of 590,976 adults with at least one negative PCR and no positive PCR were age- and sex-matched. Since the Israeli vaccination program was initiated on 20 December 2020, the time-period matching of the control cohort was calculated backward from 15 December 2020. Nine post-COVID-19 patients developed myocarditis (0.0046%), and eleven patients were diagnosed with pericarditis (0.0056%). In the control cohort, 27 patients had myocarditis (0.0046%) and 52 had pericarditis (0.0088%). Age (adjusted hazard ratio [aHR] 0.96, 95% confidence interval [CI]; 0.93 to 1.00) and male sex (aHR 4.42; 95% CI, 1.64 to 11.96) were associated with myocarditis. Male sex (aHR 1.93; 95% CI 1.09 to 3.41) and peripheral vascular disease (aHR 4.20; 95% CI 1.50 to 11.72) were associated with pericarditis. Post COVID-19 infection was not associated with either myocarditis (aHR 1.08; 95% CI 0.45 to 2.56) or pericarditis (aHR 0.53; 95% CI 0.25 to 1.13). We did not observe an increased incidence of neither pericarditis nor myocarditis in adult patients recovering from COVID-19 infection.”
Comments